Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy

Reprogramming Cancer Immunotherapy
DOI: 10.1016/j.apsb.2025.04.002 Publication Date: 2025-04-06T23:43:45Z